Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

por Schnober D, Hubatsch DA, Scherzer ML
Publicado 2015

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

por Laube T, Cooper H, Schnober D, Spraul C, Thelen U, Froböse M, Eschstruth P, Mäder B, von Kistowski G, Ramez O, Pfennigsdorf S
Publicado 2012